Contact Information
Company Information
Company
Accent Therapeutics, Inc.
Total Funding
178000000.0
Technologies
Mimecast
Amazon AWS
Typekit
Google Tag Manager
Google Analytics
Amadesa
Mobile Friendly
IoT
Remote
AI
Keywords
biotechnology research
cancer therapeutics
small molecule inhibitors
clinical trials
atx-559
dhx9 inhibitor
rna-modifying proteins
biomarker-driven medicine
precision oncology
brca deficient cancer
microsatellite instability
msi-h
deficient mismatch repair
dmmr
cell division
chromosomal instability
kif18a
oncology drug discovery
patient outcomes
cancer treatment innovation
translational research
first-in-class therapies
best-in-class drugs
pharmacodynamics
pharmacokinetics
solid tumors
treatment resistance
fda clearance
clinical advisory board
anti-tumor activity
mitotic kinesin
health outcomes
tumor vulnerabilities
research collaboration
life sciences
cancer indications
compassion for patients
cancer biology
first-in-human studies
investigational new drug
cancer drug development
therapeutic targets
drug optimization
preclinical studies
high unmet medical need
clinical pipeline
therapeutic modalities
innovative cancer solutions
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans